Valuation: McKesson Corporation

Capitalization 106B 90.32B 83.59B 78.71B 147B 9,861B 150B 981B 384B 4,735B 398B 389B 16,872B P/E ratio 2026 *
24.6x
P/E ratio 2027 * 21.3x
Enterprise value 108B 91.74B 84.9B 79.94B 149B 10,015B 152B 996B 390B 4,810B 404B 396B 17,136B EV / Sales 2026 *
0.26x
EV / Sales 2027 * 0.24x
Free-Float
44.98%
Yield 2026 *
0.35%
Yield 2027 * 0.38%
1 day-0.90%
1 week-2.11%
Current month+0.03%
1 month-7.35%
3 months+6.07%
6 months+13.37%
Current year+5.52%
1 week 845.52
Extreme 845.52
879.1
1 month 845.52
Extreme 845.52
959.95
Current year 794.59
Extreme 794.59
999
1 year 637
Extreme 637
999
3 years 352.34
Extreme 352.34
999
5 years 180.42
Extreme 180.415
999
10 years 106.11
Extreme 106.11
999
Manager TitleAgeSince
Chief Executive Officer 59 31/03/2019
Director of Finance/CFO 57 31/12/2017
Chief Tech/Sci/R&D Officer 53 02/10/2023
Director TitleAgeSince
Chairman 75 31/03/2022
Director/Board Member 70 23/04/2018
Director/Board Member 59 31/03/2019
Change 5d. change 1-year change 3-years change Capi.($)
-0.90%-2.11%+25.57%+136.39% 106B
-0.13%+0.69%+63.56%+169.57% 50.72B
-0.37%+1.13%-10.33% - 21.93B
+0.28%-0.66%-2.57%-24.52% 9.24B
+0.41%-0.87%-7.94%-18.87% 8.42B
-0.76%0.00%+17.40%-14.26% 8.34B
+1.36%-0.98%+44.21%+29.09% 6.09B
+0.16%-1.35%+11.67%+15.49% 5.77B
+1.52%+1.52%+11.20%-2.87% 3.91B
-3.45%-3.89%+29.44%+51.94% 3.72B
Average -0.19%-0.55%+18.22%+38.00% 22.42B
Weighted average by Cap. -0.48%-0.45%+27.89%+113.76%

Financials

2026 *2027 *
Net sales 408B 348B 322B 303B 565B 37,992B 576B 3,778B 1,478B 18,244B 1,533B 1,500B 65,003B 441B 376B 348B 328B 610B 41,049B 623B 4,082B 1,597B 19,712B 1,656B 1,621B 70,234B
Net income 4.27B 3.63B 3.36B 3.17B 5.9B 397B 6.02B 39.46B 15.44B 191B 16.01B 15.67B 679B 4.89B 4.17B 3.86B 3.63B 6.76B 455B 6.9B 45.25B 17.71B 219B 18.36B 17.97B 779B
Net Debt 1.66B 1.42B 1.31B 1.23B 2.3B 155B 2.35B 15.38B 6.02B 74.25B 6.24B 6.11B 265B 1.36B 1.16B 1.07B 1.01B 1.88B 126B 1.92B 12.56B 4.91B 60.64B 5.09B 4.99B 216B
Logo McKesson Corporation
McKesson Corporation specializes in pharmaceutical product distribution. The group also offers technological services to healthcare companies. Net sales break down by activity as follows: - distribution of pharmaceutical products (91.3%); - distribution of medical and surgical products (3.1%); - other (1.5%): primarily technology services and software sales. The remaining net sales (4.1%) are from international activities.
Employees
44,000
Date Price Change Volume
10/04/26 865.60 $ -0.90% 615,265
09/04/26 873.43 $ +0.26% 593,241
08/04/26 871.18 $ +1.70% 875,724
07/04/26 856.62 $ -0.02% 892,153
06/04/26 856.77 $ -3.11% 803,716
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
17
Last Close Price
865.60USD
Average target price
991.67USD
Spread / Average Target
+14.56%

Quarterly revenue - Rate of surprise